Recent developments on ketolides and macrolides
Current medicinal chemistry, 2001 - ingentaconnect.com
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
[引用][C] Recent developments on ketolides and macrolides
YJ WU, WG SU - Current medicinal chemistry, 2001 - pascal-francis.inist.fr
Recent developments on ketolides and macrolides CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Recent developments on ketolides and macrolides
YJ Wu, WG Su - Current medicinal chemistry, 2001 - pubmed.ncbi.nlm.nih.gov
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
Recent developments on ketolides and macrolides.
YJ Wu, WG Su - Current Medicinal Chemistry, 2001 - europepmc.org
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
Recent Developments on Ketolides and Macrolides
YJ Wu, WG Su - Current Medicinal Chemistry, 2001 - search.proquest.com
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …
drug candidates, HMR-3647 and ABT-773, for the treatment of community-acquired bacterial …